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Revascularization for acute mesenteric ischemia
Evan J. Ryer, MD,a Manju Kalra, MBBS,a Gustavo S. Oderich, MD,a Audra A. Duncan, MD,a
Peter Gloviczki, MD,a Stephen Cha, MS,b and Thomas C. Bower, MD,a Rochester, Minn
Objective: Acute mesenteric ischemia (AMI) remains difficult to diagnose, carries a high rate of complications, and is
associated with significant mortality. We evaluated our experience with AMI over the last 2 decades to evaluate changes
in management and assess current outcomes.
Methods:Data from consecutive patients who underwent arterial revascularization for AMI over a 20-year period (January
1990-January 2010) were retrospectively reviewed. Patient demographics, treatment modalities, and outcomes over the
last decade (2000-2010) were compared with those of the preceding decade (1990-1999) previously reported.
Results:Over the last 2 decades, 93 patients with AMI underwent emergency arterial revascularization. Forty-five patients
were treated during the 1990s and 48 during the 2000s. The majority of these patients were transferred from outside
facilities. Patient demographics and risk factors were similar between the 2 decades with the exception that the more
contemporary patients were significantly older (65.1  14 vs 71.3  14; P  .04). Etiology remained constant between
the groups with in situ thrombosis being the most common followed by arterial embolus. The majority of patients were
treated with open revascularization. Endovascular therapy alone or as a hybrid procedure was used in 11 total patients,
eight of which were treated in the last 10 years. The use of second-look laparotomy was much more liberal in the last
decade (80% vs 48%; P  .003) Thirty-day mortality was 27% in the 1990s and 17% during the 2000s (P  0.28). Major
adverse events occurred in 47% of patients with no difference between decades. There was no significant difference in
outcomes between open and endovascular revascularization. On univariate analysis, elevated SVS comorbidity score,
congestive heart failure, and chronic kidney disease predicted early death, while a history of chronic mesenteric ischemia
appeared protective. Onmultivariate analysis, no factor independently predicted perioperative mortality. Bowel resection
and cerebrovascular disease predicted postoperative morbidity, while advanced age and connective tissue disease predicted
long-term mortality.
Conclusions: Morbidity and mortality from AMI continues to be high. Revascularization by endovascular means,
although more frequent in the last decade, was still utilized in a minority of patients with severe AMI. Advanced ischemia
with bowel infarction at presentation, and markers of generalized atherosclerosis are predictors of poor outcome, while
history of chronic mesenteric ischemia is associated with better outcome. (J Vasc Surg 2012;55:1682-9.)
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eAcute mesenteric ischemia (AMI) is an uncommon
(1-2 per 1000 hospital admissions)1 but highly complex
clinical problem. Mortality from AMI remains high despite
an aggressive approach consisting of early diagnosis, resto-
ration of arterial perfusion, resection of nonviable intestine,
second-look laparotomy, and supportive intensive care with
an average from published reports ranging from 30% to
65%.2 Moreover, most series have not shown any improve-
ment in mortality over the last 2 decades,3 regardless of the
therapeutic approach applied. While major advances in the
technology and availability of imaging modalities have
made earlier diagnosis and treatment more feasible, this has
been counterbalanced by the contemporary AMI patient
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1682resenting at an advanced age and with more severe under-
ying comorbidities. Since traditional treatment, consisting
f surgical embolectomy or bypass grafting, has yielded
nly modest improvements, some4 have championed an
ndovascular-first treatment paradigm. Indeed, endovascu-
ar treatment does offer some theoretic advantages and
imilar to chronic mesenteric ischemia (CMI), it is being
ncreasingly used for revascularization of AMI.4-8 How-
ver, this technique has not been widely adopted, long-
erm outcomes remain unknown, and does not allow for
ssessment of intestinal viability. In an effort to understand
nd influence factors contributing to the high morbidity
nd poor overall survival associated with AMI, we evaluated
hanges in presentation, management, and factors affecting
utcome of AMI over the last 20 years.
ETHODS
The study was approved by the Institutional Review
oard of the Mayo Clinic. A retrospective database of
atients treated for AMI from 1990 to 2010 was reviewed.
he study comprised 93 consecutive patients treated for
MI with arterial revascularization  laparotomy. In an
ffort to evaluate treatment modalities that can be imme-
iately affected, only patients with thrombotic or embolic
tiologies for AMI were included, while patients with mes-
nteric venous occlusion or nonocclusive mesenteric isch-
i
e
t
u
m
P
c
w
M
c
R
p
u
A
t
E
(
r
c
m
e
w
y
t
B
r
a
p
d
p
rction
JOURNAL OF VASCULAR SURGERY
Volume 55, Number 6 Ryer et al 1683emia were excluded from this analysis. Treatment trends
between 1990-1999 and 2000-2010 were analyzed to
identify changes in practice paradigm. Demographics, clin-
ical characteristics, radiologic, and operative data were ob-
tained from the medical records. Etiologic classification of
AMI was based on the sum of data collected from the
dictated operative report, clinical presentation, radio-
graphic findings, and operative findings. Symptoms on
presentation, preoperative imaging, and laboratory values
on admission were recorded from the initial surgical con-
sultation. Operative risk was assessed using the Society for
Vascular Surgery/American Association for Vascular Sur-
gery (SVS/AAVS) Comorbidity Severity Score.9 Endovas-
cular or hybrid treatment included thrombolysis, mechan-
ical thrombectomy, visceral artery angioplasty, and stenting
performed with or without laparotomy. Open revascular-
ization included laparotomy with assessment of mesenteric
vasculature, surgical embolectomy, endarterectomy 
patch angioplasty, or bypass grafting in conjunction with
assessment of bowel viability. Acute renal failure in the
postoperative period was defined as creatinine 1.5
mg/dL in patients with normal preoperative renal function
or an increase of 20% in patients with chronic renal
failure. Respiratory failure included patients requiring intu-
bation 72 hours. Myocardial infarction (MI) was diag-
nosed based on electrocardiogram changes and elevation of
biochemical markers. The diagnosis of stroke was based on
clinical examination in conjunction with cerebral imaging.
Major complications included repeat intestinal ischemia,
stroke, acute renal failure requiring hemodialysis, MI, car-
diac arrest, respiratory failure requiring tracheostomy, or
multisystem organ failure.
Statistical analysis. Data were analyzed using SVS
Table I. Demographics, cardiovascular risk factors, and pe
undergoing arterial revascularization from 1990-2010
Variable 1990-2010 (N 93) (%) 1
Age (mean  SD) 68.3  15
Male gender 35 (38)
OSH transfer 49 (53)
HTN 73 (78)
Hyperlipidemia 27 (29)
Atrial fibrillation 20 (22)
Smoking history 62 (67)
COPD 18 (19)
Diabetes mellitus 26 (28)
Prior MI 20 (22)
CHF 17 (18)
CKD (Cr  1.5 mg/dL) 23 (25)
Thrombophilia 9 (10)
Prior CMI history 40 (43)
Vasculitis 5 (5)
Connective tissue disease 7 (8)
SVS comorbidity score —
Follow-up (years) 2.6  3.4
AMI, Acute mesenteric ischemia; CHF, congestive heart failure; CKD, chron
pulmonary disease; Cr, creatinine; HTN, hypertension; MI, myocardial infa
Surgery.reporting standards.10 Endpoints were mortality, morbid- aty, and survival. Survival was analyzed using Kaplan-Meier
stimates, and differences were determined by the log-rank
est. The multivariate Cox proportional hazard model was
sed to identify independent predictors of morbidity and
ortality on patients treated between 2000 and 2010. The
earson 2 or Fisher exact test was used for analysis of
ategoric variables. Differences between means were tested
ith two-sided t-test, the Wilcoxon rank-sum test, or the
ann-Whitney test. A P value of.05 determined statisti-
al significance.
ESULTS
Clinical characteristics. During the study period, 93
atients (35 males and 58 females) were identified who
nderwent arterial revascularization  laparotomy for
MI. The mean age was 68  15 years. The majority of
hese patients were transferred from outside facilities (53%).
tiology of AMI included in situ thrombosis in 50 patients
54%) and embolism in 29 patients (31%). A summary of
elevant demographic characteristics and comorbidmedical
onditions are listed in Table I.
Recent reports examining AMI outcomes reveal only
odest improvement and little optimism, therefore, we
lected to compare our contemporary results (2000-2010)
ith those from our previous report encompassing the
ears 1990 through 1999.11 Forty-five patients were
reated from 1990 to 1999 and 48 from 2000 to 2010.
oth groups had similar demographics and cardiovascular
isk factors (Table I), with the exception of a greater mean
ge (65.1 vs 71.3 years; P  .04) in the contemporary
atients and a higher incidence of hyperlipidemia, likely
ue to a more keen awareness of this diagnosis in contem-
orary medical practice (18% vs 40%; P  .02). Symptom-
erative risk assessment in 93 patients with AMI
999 (n  45) (%) 2000-2010 (n  48) (%) P value
65.1  14 71.3  15 .04
18 (40) 17 (35) .67
19 (42) 30 (63) .06
33 (73) 40 (83) .31
8 (18) 19 (40) .02
9 (20) 11 (23) .80
31 (69) 31 (65) .82
8 (18) 10 (21) .80
13 (28) 13 (20) 1.0
12 (27) 8 (17) .31
12 (27) 5 (10) .06
14 (31) 9 (19) .23
5 (11) 4 (8) .74
19 (42) 21 (43) 1.0
3 (7) 2 (4) .69
3 (7) 4 (8) 1.0
— 7.0  0.7 —
2.9  4 2.3  2 .40
ney disease; CMI, chronic mesenteric ischemia; COPD, chronic obstructive
; OSH, outside hospital; SD, standard deviation; SVS, Society for Vascularriop
990-1
ic kidtology and presentation laboratory values did not differ
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June 20121684 Ryer et albetween groups (Table II). Abdominal pain was the most
common presenting symptom and all patients presented
with either pain and/or tenderness on abdominal examina-
tion. Other common symptoms on presentation included
nausea, vomiting, and diarrhea. Frequent laboratory find-
ings included a leukocytosis (mean, 17.9  7  109/L)
and an elevated lactate (mean, 3.4 2 mmol/L). Imaging
of the mesenteric vasculature varied between the two peri-
ods (Table II). Nearly all patients treated in the 1990s
(87%) had conventional angiography, compared with 46%
in the more recent group (P  .0001). The use of com-
puted tomographic angiography (CTA) increased from
31% in the 1990s to 83% in the 2000s (P .0001). The use
of duplex ultrasound was similar between the time periods
and understandably was sparsely used (8.6%). The etiology
of AMI was similar between the time periods with mesen-
teric artery in situ thrombosis being the most common
(1990s: n  25 [56%] vs 2000s: n  24 [50%], P  .68).
The thrombotic occlusions occurred in one stent and two
previous bypasses occlusions between 2000 and 2010 (Ta-
ble II).
Surgical interventions. The majority of patients
treated over this 20-year time period (n 82, 88%) under-
went open arterial revascularization (Table III). A variety of
surgical interventions were performed, which included
Table II. Clinical presentation, preoperative laboratory va
undergoing arterial revascularization from 1990-2010
Variable 1990-1999 (n  45)
Clinical presentation
Mean temp (°C) 36.6  1.1
Mean HR (bpm) 96  21
Mean SBP (mm Hg) 141  35
Mean DBP (mm Hg) 75  20
Abdominal pain 41 (91)
Constipation 2 (4)
Diarrhea 17 (38)
LGIB 7 (16)
Nausea 19 (42)
Vomiting 16 (36)
Abdominal tenderness 26 (58)
Pain out of proportion 19 (42)
Presentation laboratories
Leukocytes (109/L) 19  8
Bicarbonate (mmol/L) 22  4
Cr (mg/dL) 1.3  0.7
pH 7.37  0.1
Base deficit (mmol/L) 3.0  5
Lactate (mmol/L) 4.0  3
Preoperative imaging
ultrasound 3 (7)
CT 14 (31)
Angiography 39 (87)
Etiology
Arterial embolus 13 (29)
Arterial thrombosis 25 (56)
Bypass occlusion 7 (16)
Stent occlusion 0 (0)
Aortic dissection 0 (0)
AMI, Acute mesenteric ischemia; CT, computed tomography; LGIB, lowermesenteric thromboembolectomy (n  37, 45%) pros- ihetic bypass grafting (n  33, 40%), endarterectomy 
atch angioplasty (n  6, 7%), and autologous saphenous
ein bypass grafting (n  6, 7%). Prosthetic grafts were
sed only in situations where no suitable autologous con-
uit was available. If the use of a prosthetic graft was
ombined with resection of necrotic bowel, it was soaked in
ifampin prior to implantation and excluded with omentum
rior to performing enterectomy.
When comparing the contemporary group to patients
ared for in the 1990s, there was no difference in the type of
rocedure performed or the configuration of the bypass
rafts. However, among patients who had mesenteric by-
ass grafting procedures performed with a synthetic con-
uit, there was significantly greater use of rifampin-soaked
acron conduits in the more contemporary group (n  1
s n  8; P  .005). Resection of necrotic bowel at the
nitial surgery was necessary in 33 patients (40%). A second-
ook laparotomy was performed in 52 patients (63%), sig-
ificantly more in the last decade (48% vs 80%; P  .003).
mong these 52 patients, 38% (n  20) had a positive
econd-look laparotomy and underwent additional bowel
esection.
Endovascular therapy alone or as a hybrid procedure
as used in 11 total patients (12%), eight of which were
reated in the 2000s. The type of procedures performed
imaging, and etiology in 93 patients with AMI
2000-2010 (n  48) (%) P value
36.7  0.7 .92
91  22 .29
150  31 .19
75  20 1.0
47 (98) .20
1 (2) .61
11 (23) .17
6 (13) .77
18 (38) .68
13 (27) .50
38 (79) .04
14 (29) .20
17  6 .05
24  5 .09
1.2  0.8 .52
7.37  0.1 .92
2.2  5 .49
3.1  2 .13
5 (10) .72
40 (83) .0001
22 (46) .0001
16 (33) .66
24 (50) .68
5 (10) .54
1 (2) 1.0
2 (4) .50
intestinal bleeding.lues,
(%)ncluded thrombolysis/mechanical thrombectomy (n 5)
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Seven of the 11 endovascular patients required laparotomy
for bowel assessment, five of which underwent resection of
necrotic bowel. All patients undergoing an endovascular
intervention and a laparotomy had the latter performed
immediately following intervention in the hybrid operating
room or the radiology suite.
Patient outcomes. Thirty-day operative mortality in
the entire patient cohort was 22% (20/93); 12 in the 1990s
(27%) and eight (17%) in the 2000s (P  .28). The mean
age of patients dying was 73.9  13.9 years and causes of
death included ongoing mesenteric ischemia with intra-
abdominal sepsis and multiorgan failure (n  6), MI/
cardiac arrest (n  7), hemorrhage (n  1), and health
care proxy-desired comfort measures only (n  6).
Overall, complications occurred in 68% of patients,
73% treated in the 1990s and 63% treated in the 2000s (P
.28). Major complications, defined as death, repeat intesti-
nal ischemia, stroke, acute renal failure requiring hemodi-
alysis, MI, cardiac arrest, respiratory failure requiring tra-
cheostomy, or multisystem organ failure occurred in 44 of
the 93 patients (47%), 23 patients (51%) treated in the
1990s and 21 (44%) treated in the 2000s (P  .53; Table
IV). The most common complications were respiratory
failure (n 13) followed by MI (n 8). The mean length
of hospital stay was 23.1 days for the 1990s and 23.9 days
for the last decade with no significant difference (P .88).
There were no significant differences with regard to demo-
graphics or outcomes between AMI patients treated by
endovascular means or traditional surgical therapy.
Because we have previously published risk factor anal-
ysis on patients from 1990 to 1999,11 we limitedmulti- and
Table III. Technical details of 93 patients with AMI unde
Variable
Open revascularization
Embolectomy
Endarterectomy  patch
Arterial bypass
Bypass conduit
Vein
Synthetic
Rifampin soaked
Bypass configuration
Antegrade
Retrograde
Bowel resection at first look
Second-look laparotomy
Bowel resection at second look
30-day mortality
Endovascular/hybrid revascularization
Thrombolysis
Celiac angioplasty/stent
SMA angioplasty/stent
Celiac and SMA angioplasty/stent
Mechanical thrombectomy and SMA angioplasty/stent
30-day mortality
AMI, Acute mesenteric ischemia; SMA, superior mesenteric artery.univariate analysis in the current report to patients treated sn the last decade. Factors associated with early death (30
ays from initial surgery) by univariate analysis included
resentation Cr (P  .002), SVS cardiac score (P  .04),
VS composite score (P  .01), congestive heart failure
P .01), or chronic kidney disease (P .003; Table V). In
ontrast, acute-on-chronic mesenteric ischemia appeared
rotective for mortality (P  .04). On multivariable analy-
is, no factors remained predictive for early death. Factors
ssociated with postoperative complications by univariate
nalysis included presentation heart rate (P .049), leuko-
yte count (P  .008), lactate level (P  .006), congestive
eart failure (P  .007), or prior transient ischemic attack
TIA)/stroke (P  .005; Table VI). Independent predic-
ors, on multivariate analysis, of any or major postoperative
omplication were bowel resection at initial surgery (hazard
atio [HR], 17.14; 95% confidence interval [CI], 2.00-
46.76; P .009) and prior TIA/stroke, respectively (HR,
.99; 95% CI, 1.86-53.7; P  .007) (Table VI).
The mean follow-up was 2.6  3.4 years and did not
iffer between the 2 decades (2.9  4 months vs 2.3 2
ears; P  .40). There were 36 late deaths. Overall 1-year
urvival (Fig) was not significantly different between the
990s (49%) and the 2000s (69%; P .11). The mean age
t death was 70.913 years and occurred 2.572.4 years
ollowing their presentation with AMI. The cause of death
ould not be determined in 22 of the late deaths. Known
auses of death were renal failure in four, cardiac disease in
hree, malignancy in three, chronic obstructive pulmonary
isease (COPD) in two, and urosepsis in one. There was
nly one record of abdominal symptoms at the time of
eath. On univariate analysis, factors associated with late
ortality included advanced age (P .02), SVS composite
ng arterial revascularization from 1990-2010
-1999 (n  45) (%) 2000-2010 (n  48) (%) P value
42 (93) 40 (83) .20
15 (33) 22 (55) .12
5 (11) 1 (3) .20
22 (49) 17 (42) .39
4 (20) 2 (12) .68
17 7 .045
1 8 .005
10 (45) 10 (59) .52
12 (55) 7 (41) .52
18 (43%) 15 (38%) .66
20 (48) 32 (80) .003
9 (21) 11 (28) .61
11 (26) 5 (13) .06
3 (7) 8 (17) .20
2 (67) 2 (25) .50
0 (0) 2 (25) 1.0
1 (33) 2 (25) 1.0
0 (0) 1 (13) 1.0
0 (0) 1 (13) 1.0
1 (33) 3 (38) 1.0rgoi
1990core (P .001), being transferred from an outside facility
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connective tissue disease (P  .036), or having a major
postoperative complication (P  .004). On multivariate
analysis, predictors of late mortality were age (HR, 1.06;
95% CI, 1.01-1.11; P  .015), connective tissue disease
(HR, 4.92; 95% CI, 1.19-20.21; P  .03), and having a
major postoperative complication (HR, 5.25; 95% CI,
1.88-14.67; P  .0015).
DISCUSSION
The mortality rate of AMI has declined from 80% to
90% in the 1970s to 60% to 70% in the 1980s and
1990s.12,13 The aforesaid improvement in survival is
thought to be multifactorial and often attributed to a
Table IV. Early periprocedural complications in 93 patien
2010
Variable 1990-199
30-day mortality
1-year mortality
Mean hospital stay 23.1
Any complication
Major complication
Total complications
Cardiac complications
MI
Arrhythmia
Cardiac arrest
Pulmonary complications
Pneumonia
Pleural effusion
Respiratory failure requiring tracheostomy
Pulmonary embolism
ARDS
Renal complications
Acute renal failure
Acute renal failure requiring hemodialysis
Neuro (TIA/stroke)
GI complications
C. Difficile colitis
Hepatic failure
Perforated duodenal ulcer
Recurrent ischemia
Prolonged ileus
Bowel obstruction
Biliary leak
Lower GI bleeding
Cholecystitis
Surgical complications
Mesenteric artery/graft thrombosis
Re-exploration for bleeding
ACS
Surgical site infection
Splenic injury requiring splenectomy
Additional complications
Urinary tract infection
Heparin-induced thrombocytopenia
Deep venous thrombosis
ACS, Abdominal compartment syndrome; AMI, acute mesenteric ischemia
CHF, congestive heart failure; GI, gastrointestinal; MI, myocardial infarctio
Major complications include repeat intestinal ischemia, stroke, acute rena
tracheostomy, or multisystem organ failure.higher index of suspicion among clinicians, advances in cadiographic diagnosis, and aggressive surgical approach
ith better perioperative care. However, this rate of im-
rovement has not persisted and in this retrospective
ingle-institution experience, we found that the mortality
emains high with only a modest improvement when com-
ared to the prior decade.
This study aimed to evaluate contemporary results of
evascularization for AMI and compare them to our previ-
us experience. Similar to our prior report,11 we found in
itu thrombosis remained the most common etiology of
MI. Furthermore, only 40% of our patients had symp-
oms suggestive of chronic mesenteric insufficiency, thus
aking early diagnosis challenging. Abdominal pain, often
ccompanied by an elevated leukocyte count and lactate
th AMI undergoing arterial revascularization from 1990-
 45) (%) 2000-2010 (n  48) (%) P value
7) 8 (17) .28
1) 15 (31) .11
8 days 23.9  16 days .88
3) 30 (63) .28
1) 21 (44) .53
43
2) 6 (14) .33
3
1
2
2) 7 (16) .13
0
1
4
1
1
2) 5 (12) 1.0
4
1
) 1 (2) .61
) 11 (26) .04
1
1
0
1
1
3
1
1
2
) 8 (18) .20
0
3
2
2
1
5) 5 (12) .75
3
2
0
S, acute respiratory distress syndrome; C. Difficile, Clostridium Difficile;
, transient ischemic attack.
e requiring hemodialysis, MI, cardiac arrest, respiratory failure requiringts wi
9 (n
12 (2
23 (5
 1
33 (7
23 (5
41
9 (2
5
0
4
13 (3
4
0
9
0
0
5 (1
5
0
2 (5
3 (7
1
1
1
1
0
0
0
0
0
3 (7
1
0
0
2
0
6 (1
5
0
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was found in only 35% of patients. Dynamic CTA with
three-dimensional reconstruction has proven to be highly
sensitive and specific for the diagnosis of AMI14 and has
replaced conventional angiography as our imaging modal-
ity of choice. Additionally, high-quality CTA also offers the
ability to exclude other causes of abdominal pain and some
ability to assess bowel perfusion.15
In this study, revascularization continued to be mainly
accomplished with open surgical techniques in contrast to
recently reported national trends, although our use of
endovascular techniques is increasing. Over the last decade,
the use of endovascular therapy for treatment of patients
with AMI has escalated dramatically at most institutions
and has been associated with lower mortality than tradi-
tional open surgical therapy.4,5 Schemmerhorn and associ-
ates evaluated the Nationwide Inpatient Sample from 1988
to 2006 and reported that 35% of patients presenting with
AMI underwent angioplasty and stenting, while only 65%
were treated with embolectomy, surgical bypass, or endar-
Table V. Pearson’s 2 test analysis of independent factors
patients with AMI undergoing arterial revascularization fro
Variable N
Univariate analysis (Pearson’s 2test)
Early death (30 days) N
SVS cardiac score 1.18
SVS renal score 0.36
SVS sum clinical score 9.54
Presentation Cr (mg/dL) 1.05
CHF 2
CKD (Cr 1.5 mg/dL) 0
Acute-on-chronic MI 19
Major post-op complication N
Presentation heart rate (bpm) 85.15
Presentation leukocytes (109/L) 14.46
Presentation lactate 2.42
CHF 0
Prior TIA/stroke 3
AMI, Acute mesenteric ischemia; bpm, beats per minute; CHF, congestive h
creatinine; MI, myocardial infarction; OSH, outside hospital; SVS Score, Soc
Table VI. Multivariate analysis of independent factors asso
survival in 48 patients with AMI undergoing arterial revasc
Variable
Multivariate analysis (Cox proportional hazards model)
Early death (30 days)
No predictors
Any post-op complication
Bowel resection at initial surgery
Major post-op complication
Prior TIA/stroke
Overall survival
Age
Connective tissue disorder
Major post-op complication
AMI, Acute mesenteric ischemia; TIA, transient ischemic attack.terectomy.5 In addition, mortality rates were 16% for pa- gients undergoing endovascular vs 39% for traditional re-
ascularization (P  .001) despite patients in the
ndovascular group being older with more comorbidities.
owever, because of the limitations of this data set, it is
ifficult to assess howmany of these endovascular interven-
ions were performed in patients with severe acute vs sub-
MI, a factor that would significantly influence outcome.
n this regard, it was noted that bowel resection was re-
uired in 37% of patients undergoing surgical treatment vs
8% following endovascular therapy. Undoubtedly, the
umber of endovascular interventions, for acute mesenteric
cclusive disease will continue to increase in the future and
ill no longer be reserved for high-risk patients or those
ith less severe pathology. This fact is highlighted by a
ecent single-institution publication from the Cleveland
linic by Arthurs et al4 in which 56 of 70 patients with AMI
nderwent initial endovascular treatment. The group dem-
nstrated a high success rate with only nine of 56 treatment
ailures and a lower in-hospital mortality rate with endovas-
ular treatment of AMI compared to traditional open sur-
iated with early death and postoperative morbidity in 48
00-2010
t Event P value
N  9
.76 1.78  0.83 .041
.63 1.33  1.00 .001
.56 14.11  5.18 .011
.42 1.94  1.52 .002
3 (33%) .013
2 (22%) .003
) 1 (11%) .039
N  29
6.71 97.48  24.83 .049
.94 19.26  5.94 .008
.55 3.9  1.97 .006
5 (24%) .007
) 10 (48%) .005
ilure; CMI, chronic mesenteric ischemia; CKD, chronic kidney disease; Cr,
f Vascular Surgery Comorbidity Score; TIA, transient ischemic attack.
d with early death, postoperative morbidity, and overall
zation from 2000-2010
Hazard ratio 95% CI P value
17.139 2.002-146.757 .0095
9.999 1.860-53.745 .0073
1.059 1.011-1.109 .0153
4.921 1.198-20.210 .0270
5.254 1.881-14.673 .0015assoc
m 20
o even
 39
 0
 0
 4
 0
(5%)
(0%)
(49%
 27
 1
 5
 1
(0%)
(11%
eart faciate
ulariical treatment (36% vs 50%; P  .05).
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gical revascularization in this study, our 30-day mortality of
17% in the last decade compares favorably to contemporary
series of endovascular treatment. We did not find any
difference between endovascular and traditional treatment
groups in this series of patients with severe AMI. We can
only speculate as to the reasons for the low use of endovas-
cular therapy in the last decade despite the liberal use in
patients with CMI at our institution. At the outset, patients
whowere deemed to have sub-AMI by the vascular surgeon
were excluded from this analysis. Additionally, since the
majority of our patients were referred from outside facili-
ties, they presented with more prolonged ischemia-making
assessment of intestinal viability more compulsory and
likely rendering endoluminal therapy alone less feasible.
This is supported by the fact that 40% of patients in our
series had necrotic bowel at their initial laparotomy. No
doubt an increasing proportion of such patients will be
deemed suitable for hybrid treatment with retrograde
stenting of the superior mesenteric artery (SMA) in the
future. On review of the literature for results of open
surgical revascularization for AMI, our contemporary re-
sults compare very favorably with other reports from re-
ports of large tertiary care centers. For example, a recent
report from Kougias et al evaluated 72 patients who under-
went open arterial revascularization by a variety of tech-
niques. The 30-day mortality rate was 31% and advanced
age was predictive of mortality on multivariate analysis.2
Similarly, Edwards et al16 reviewed 41 patients with AMI
undergoing traditional revascularization and two patients
being treated with visceral angioplasty and stenting. They
reported a 62% perioperative mortality. Lastly, Endean et
al17 reported on 43 patients with arterial AMI. All patients
underwent traditional open revascularization with a re-
ported 60% perioperative mortality rate.
We hypothesize that the trend toward decreased 30-
Fig. Kaplan-Meier estimates of overall patient survival in 93 pa-
tients with acute mesenteric ischemia (AMI) undergoing arterial
revascularization from 1990-2010.day mortality from 27% in the 1990s to 17% during the n000s is, at least in part, related to an increased use of
econd-look laparotomy. Comparing the 2 decades span-
ing this study, the number of patients undergoing second-
ook operation has significantly increased (48% vs 80%; P
003). This is in contrast to nationwide trends that show the
umber of patients undergoing a second-look operation
as remained the same or has decreased, with only a frac-
ion of patients operated on for AMI undergoing a second-
ook procedure.18,19 In our contemporary cohort, the
umber of patients undergoing a second-look laparotomy
as 80% with 28% having necrotic bowel requiring resec-
ion at the second look. We feel strongly that the vast
ajority of patients should undergo a second-look lapa-
otomy because assessment of the full extent of visceral
schemia is unreliable at the initial surgery, even when
ntraoperative Doppler ultrasonography and intravenous
uorescein are utilized (in this series both were utilized
n 30% of cases). This is likely due to the fact that in
MI, the serosa often appears viable despite infarction of
he underlying intestinal mucosa.19 Therefore, a second-
ook exploration is the only way to establish the full
xtent of nonviable bowel.
Despite the small improvement in mortality, AMI-
ssociated morbidity and length of hospitalization re-
ained stable and continues to be substantial. Forty-four
atients (47%) suffered a major postoperative complication
nd average length of stay exceeds 20 days (mean 24 17
ays) with no significant improvement in either of these
arameters throughout this 20-year period. When search-
ng for clinical predictors of outcome in patients with AMI,
e found that on univariate analysis, the SVS clinical score,
erum Cr, residing in a nursing home, and having conges-
ive heart failure were all predictors of postoperative mor-
ality. In contrast, having chronic mesenteric ischemia was
rotective against early mortality. We hypothesize that this
s due to increased collateralization allowing for better
olerance of visceral ischemia. Additionally, we found that
owel resection at initial surgery and cerebrovascular dis-
ase predicted postoperative morbidity, while advanced
ge, connective tissue disease, and having a major postop-
rative complication predicted long-termmortality onmul-
ivariate analysis. We accept that many of these predictors
re in fact interrelated. For example, a high SVS clinical
core, advanced age, residing in a nursing home, abnormal
erum Cr, and a previous cerebrovascular event are all
actors indicative of either advanced atherosclerotic disease
r poor overall health. A common theme among other
ontemporary reports of treatment for AMI is also that
dvanced age and visceral ischemia are predictors of poor
utcome.2,14,16,19
This study shows an evolving treatment paradigm and
odest improvement in outcomes with this traditionally
ighly lethal problem. However, our study has several
hortcomings, which need to be discussed. First, several
actors that contribute to the decision on type of recon-
truction (open vs endovascular, antegrade vs retrograde,
tc.) are difficult to evaluate because of the retrospective,
onrandomized study design. Secondly, only patients un-
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analysis. Furthermore, multiple surgeons treated these het-
erogenous patients over a 20-year time period. Lastly, the
small number of patients in subgroups, especially those
treated by endoluminal means, has likely introduced type II
error, and it is possible that differences in variables and
outcomes would reach statistical significance with a larger
patient population.
In summary, morbidity and mortality from AMI re-
mains high. There has been no significant change in survival
over the last 2 decades despite an aging patient population
and the more liberal use of second-look laparotomy. Revas-
cularization by endovascular means has increased in the last
decade. Bowel infarction at presentation and markers of
generalized atherosclerosis are predictors of poor outcome,
while history of chronic mesenteric ischemia is associated
with better outcome.
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